Hybrid business models explore - A case study of M’s company

by SHENG PING YU, 游勝評
Published 2016

Characterization of OsCDPK1、OsPII、OsAreA and Protease Inhibitor Related Genes in Rice

by Sheng-Ping Yu, 于聖平
Published 2013

New knowledge of the diagnosis and treatment of primary central nervous system lymphoma

by Xue⁃jun YANG, Bin ZHANG, Sheng⁃ping YU
Published 2010-10-01

Study on invasion and migration of malignant glioma

by Xue-jun YANG, Long HAI, Sheng-ping YU
Published 2018-01-01

Preliminary application of intraoperative magnetic resonance imaging combined with neuronavigation in glioma surgery

by Sheng⁃ping YU, Jian SUN, Kai YU, Qiang HUANG, Hao⁃lang MING, Yan ZHAO, Wei HAN, Xue⁃jun YANG
Published 2012-12-01

Regulation of tumor immunity by metabolism of glioma cells and immune cells in tumor microenvironment

by Yi⁃ming ZHANG, Sheng⁃ping YU, Pei⁃dong LIU, Tao LI, Liang ZHANG, Yang XIE, Jia⁃bo LI, Jin⁃hao ZHANG, Xiao⁃guang FAN, Xue⁃jun YANG
Published 2020-02-01

Shifting in the Dominant Bacterial Group Endozoicomonas Is Independent of the Dissociation With Coral Symbiont Algae

by Jia-Ho Shiu, Jia-Ho Shiu, Jia-Ho Shiu, Sheng-Ping Yu, Chia-Ling Fong, Jiun-Yan Ding, Chih-Jui Tan, Chih-Jui Tan, Tung-Yung Fan, Chih-Ying Lu, Sen-Lin Tang, Sen-Lin Tang
Published 2020-07-01

MRI combined with 18F -FDG PET and 11C -MET PET in differentiating tumefactive demyelinating lesion and glioma

by Yi-han YANG, Li CAI, Hai-wen MA, Ying WANG, Yu BAI, Hao-lang MING, Sheng-ping YU, Bing-cheng REN, Yu LIN, Kai ZHANG, Long HAI, Wei WANG, Cheng CHENG, Tao LI, Xue-jun YANG
Published 2017-10-01

MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma

by Jin-Zhang Sun, Jin-Hao Zhang, Jia-Bo Li, Feng Yuan, Lu-Qing Tong, Xu-Ya Wang, Lu-Lu Chen, Xiao-Guang Fan, Yi-Ming Zhang, Xiao Ren, Chen Zhang, Sheng-Ping Yu, Xue-Jun Yang
Published 2021-01-01